NO20003591L - Fettsyreanaloger for behandling av kreft - Google Patents

Fettsyreanaloger for behandling av kreft

Info

Publication number
NO20003591L
NO20003591L NO20003591A NO20003591A NO20003591L NO 20003591 L NO20003591 L NO 20003591L NO 20003591 A NO20003591 A NO 20003591A NO 20003591 A NO20003591 A NO 20003591A NO 20003591 L NO20003591 L NO 20003591L
Authority
NO
Norway
Prior art keywords
sub
alkyl
fatty acid
treatment
cancer
Prior art date
Application number
NO20003591A
Other languages
English (en)
Norwegian (no)
Other versions
NO20003591D0 (no
Inventor
Rolf Berge
Original Assignee
Thia Medica As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thia Medica As filed Critical Thia Medica As
Priority to NO20003591A priority Critical patent/NO20003591L/no
Publication of NO20003591D0 publication Critical patent/NO20003591D0/no
Priority to CA002414480A priority patent/CA2414480A1/en
Priority to DE60118198T priority patent/DE60118198T2/de
Priority to PCT/NO2001/000301 priority patent/WO2002003983A1/en
Priority to MXPA02012944A priority patent/MXPA02012944A/es
Priority to AU7286001A priority patent/AU7286001A/xx
Priority to HK04100292.1A priority patent/HK1057473B/xx
Priority to AT01952065T priority patent/ATE320802T1/de
Priority to AU2001272860A priority patent/AU2001272860B2/en
Priority to BR0112399-8A priority patent/BR0112399A/pt
Priority to EP01952065A priority patent/EP1313463B1/en
Priority to ES01952065T priority patent/ES2261441T3/es
Priority to US10/312,901 priority patent/US7378443B2/en
Priority to RU2002134754/15A priority patent/RU2283105C2/ru
Priority to JP2002508437A priority patent/JP2004502732A/ja
Priority to KR1020037000477A priority patent/KR100861428B1/ko
Priority to NZ523316A priority patent/NZ523316A/en
Priority to CNB018127177A priority patent/CN100569228C/zh
Priority to KR1020087014318A priority patent/KR20080071598A/ko
Publication of NO20003591L publication Critical patent/NO20003591L/no
Priority to NO20025930A priority patent/NO324634B1/no
Priority to ZA200210028A priority patent/ZA200210028B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/255—Esters, e.g. nitroglycerine, selenocyanates of sulfoxy acids or sulfur analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20003591A 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft NO20003591L (no)

Priority Applications (21)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
KR1020087014318A KR20080071598A (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체
EP01952065A EP1313463B1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
US10/312,901 US7378443B2 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
PCT/NO2001/000301 WO2002003983A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
MXPA02012944A MXPA02012944A (es) 2000-07-13 2001-07-13 Analogos de acido graso para el tratamiento de cancer.
AU7286001A AU7286001A (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
HK04100292.1A HK1057473B (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
AT01952065T ATE320802T1 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs
AU2001272860A AU2001272860B2 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
BR0112399-8A BR0112399A (pt) 2000-07-13 2001-07-13 Análogos de ácido graxo para o tratamento de câncer
CA002414480A CA2414480A1 (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
ES01952065T ES2261441T3 (es) 2000-07-13 2001-07-13 Analogos de acidos grasos para el tratamiento del cancer.
DE60118198T DE60118198T2 (de) 2000-07-13 2001-07-13 Fettsäure-analoge zur behandlung von krebs
RU2002134754/15A RU2283105C2 (ru) 2000-07-13 2001-07-13 Аналоги жирных кислот для лечения рака
JP2002508437A JP2004502732A (ja) 2000-07-13 2001-07-13 癌治療のための脂肪酸類似体
KR1020037000477A KR100861428B1 (ko) 2000-07-13 2001-07-13 암 치료용 지방산 유사체
NZ523316A NZ523316A (en) 2000-07-13 2001-07-13 Fatty acid analogues for the treatment of cancer
CNB018127177A CN100569228C (zh) 2000-07-13 2001-07-13 用于治疗癌症的脂肪酸类似物
ZA200210028A ZA200210028B (en) 2000-07-13 2002-12-11 Fatty acid analogues for the treatment of cancer.
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft

Publications (2)

Publication Number Publication Date
NO20003591D0 NO20003591D0 (no) 2000-07-13
NO20003591L true NO20003591L (no) 2002-01-14

Family

ID=19911376

Family Applications (2)

Application Number Title Priority Date Filing Date
NO20003591A NO20003591L (no) 2000-07-13 2000-07-13 Fettsyreanaloger for behandling av kreft
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO20025930A NO324634B1 (no) 2000-07-13 2002-12-11 Fettsyreanaloger for behandling av cancer

Country Status (17)

Country Link
US (1) US7378443B2 (enExample)
EP (1) EP1313463B1 (enExample)
JP (1) JP2004502732A (enExample)
KR (2) KR100861428B1 (enExample)
CN (1) CN100569228C (enExample)
AT (1) ATE320802T1 (enExample)
AU (2) AU7286001A (enExample)
BR (1) BR0112399A (enExample)
CA (1) CA2414480A1 (enExample)
DE (1) DE60118198T2 (enExample)
ES (1) ES2261441T3 (enExample)
MX (1) MXPA02012944A (enExample)
NO (2) NO20003591L (enExample)
NZ (1) NZ523316A (enExample)
RU (1) RU2283105C2 (enExample)
WO (1) WO2002003983A1 (enExample)
ZA (1) ZA200210028B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO328803B1 (no) 2000-03-03 2010-05-18 Thia Medica Nye fettsyreanaloger
AU2003278602C1 (en) 2002-06-20 2010-08-12 Pronova Biopharma Norge As Sulfur-containing phospholipid derivatives
JP2008506773A (ja) 2004-07-19 2008-03-06 ティア メディカ アクスイェ セルスカプ タンパク質材料と非酸化性脂肪酸体を含む組成物
NO20053519L (no) * 2005-07-18 2007-01-19 Thia Medica As Anvendelse av forbindelser som omfatter fettsyrer
US8986253B2 (en) 2008-01-25 2015-03-24 Tandem Diabetes Care, Inc. Two chamber pumps and related methods
US8408421B2 (en) 2008-09-16 2013-04-02 Tandem Diabetes Care, Inc. Flow regulating stopcocks and related methods
EP2334234A4 (en) 2008-09-19 2013-03-20 Tandem Diabetes Care Inc DEVICE FOR MEASURING THE CONCENTRATION OF A SOLVED SUBSTANCE AND CORRESPONDING METHOD
US8758323B2 (en) 2009-07-30 2014-06-24 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
US9180242B2 (en) 2012-05-17 2015-11-10 Tandem Diabetes Care, Inc. Methods and devices for multiple fluid transfer
US9555186B2 (en) 2012-06-05 2017-01-31 Tandem Diabetes Care, Inc. Infusion pump system with disposable cartridge having pressure venting and pressure feedback
AU2014228387B2 (en) 2013-03-11 2016-09-01 Sciadonics, Inc. Lipid compositions containing bioactive fatty acids
WO2014140934A2 (en) 2013-03-11 2014-09-18 Life Science Nutrition As Natural lipids containing non-oxidizable fatty acids
US9173998B2 (en) 2013-03-14 2015-11-03 Tandem Diabetes Care, Inc. System and method for detecting occlusions in an infusion pump
DE102014116958B9 (de) * 2014-11-19 2017-10-05 Trumpf Laser- Und Systemtechnik Gmbh Optisches System zur Strahlformung eines Laserstrahls, Laserbearbeitungsanlage, Verfahren zur Materialbearbeitung und Verwenden einer gemeinsamen langgezogenen Fokuszone zur Lasermaterialbearbeitung
KR20180027516A (ko) * 2015-06-11 2018-03-14 유니버시티 오브 마이애미 암 치료 및 진단
CN105498622B (zh) * 2015-12-10 2017-10-17 江南大学 一种含硒表面活性剂及其制备方法和应用
CN107235880B (zh) * 2017-06-30 2018-10-30 江南大学 一种含硒阳离子表面活性剂及其应用
GB201910644D0 (en) * 2019-07-25 2019-09-11 Coegin Pharma As Cancer Treatment
AU2020405068A1 (en) 2019-12-18 2022-07-07 Stinginn Llc Substituted 1,2, 4-triazoles and methods of use
US11897888B1 (en) 2020-04-30 2024-02-13 Stinginn Llc Small molecular inhibitors of sting signaling compositions and methods of use
CN115260964A (zh) * 2022-08-29 2022-11-01 烟台市福山义昌精细化工厂 一种石油油管丝扣专用密封胶及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0686377B2 (ja) * 1985-09-30 1994-11-02 日清製粉株式会社 がん転移抑制剤
SE9103572D0 (sv) * 1991-11-29 1991-11-29 Astra Ab Organic salts of n,n'-diacetyl cystine
JPH0797320A (ja) * 1993-08-04 1995-04-11 Takuma Sasaki 制癌剤
US6358915B1 (en) * 1995-03-07 2002-03-19 George Washington University Methods for inhibiting metastasis
AU693682B2 (en) * 1995-04-10 1998-07-02 Taiho Pharmaceutical Co., Ltd. Cancerous metastasis inhibitor
NO952796D0 (no) * 1995-07-14 1995-07-14 Rolf Berge Fettsyre analoger med ikkeoksyderbart B-sete, fremstilling og anvendelse i krapeutiske preparater
DE69726182T2 (de) * 1996-12-11 2004-08-12 Dana-Farber Cancer Institute, Inc., Boston Methoden und pharmazeutische zusammenstellungen zur wachstumsverhinderung von tumorzellen enthaltend einen ppar-gamma agonisten und einen map kinase inhibitor
DE19700774A1 (de) * 1997-01-13 1998-07-16 Hoechst Ag Antiadhäsive Sulfatid-Mimetika
WO1999058120A1 (en) * 1998-05-08 1999-11-18 Rolf Berge USE OF NON-β-OXIDIZABLE FATTY ACID ANALOGUES FOR TREATMENT OF SYNDROME-X CONDITIONS
JP4993878B2 (ja) * 2005-06-28 2012-08-08 ダイキョーニシカワ株式会社 多気筒エンジンの吸気装置

Also Published As

Publication number Publication date
NZ523316A (en) 2004-09-24
ATE320802T1 (de) 2006-04-15
DE60118198T2 (de) 2007-01-25
BR0112399A (pt) 2003-05-27
KR20030016399A (ko) 2003-02-26
NO324634B1 (no) 2007-11-26
WO2002003983A1 (en) 2002-01-17
US7378443B2 (en) 2008-05-27
CN1441671A (zh) 2003-09-10
JP2004502732A (ja) 2004-01-29
ZA200210028B (en) 2004-01-26
MXPA02012944A (es) 2004-05-17
US20040024063A1 (en) 2004-02-05
AU7286001A (en) 2002-01-21
CA2414480A1 (en) 2002-01-17
DE60118198D1 (de) 2006-05-11
ES2261441T3 (es) 2006-11-16
CN100569228C (zh) 2009-12-16
KR100861428B1 (ko) 2008-10-02
RU2283105C2 (ru) 2006-09-10
NO20025930L (no) 2003-01-13
AU2001272860B2 (en) 2005-11-24
NO20003591D0 (no) 2000-07-13
NO20025930D0 (no) 2002-12-11
EP1313463A1 (en) 2003-05-28
KR20080071598A (ko) 2008-08-04
HK1057473A1 (zh) 2004-04-08
EP1313463B1 (en) 2006-03-22

Similar Documents

Publication Publication Date Title
NO20003591D0 (no) Fettsyre analoger for behandling av kreft
MX9804105A (es) Antagonistas de taquicininas a base de piperidonas.
DK1485359T3 (da) Natriumkanalblokkere
DK1075260T3 (da) Hidtil ukendte fedtsyreanaloger til behandling af sekundær restenose
KR950000728A (ko) 포스포네이트 뉴클레오티드 에스테르 유도체
DE69918087D1 (de) Topische formulierungen zur behandlung von nagel pilzerkrankungen
KR960003726A (ko) 골손실의 억제를 위한 복합 치료
DE69929877D1 (de) BENZOCHINONDERIVATE ENTHALTENDE HEMMER VON NF-kB
ES2141329T3 (es) Antifungicos azolicos solubles en agua.
RU2002134754A (ru) Аналоги жирных кислот для лечения рака
JP2004502732A5 (enExample)
NO20004844L (no) Fettsyre analoger for behandling av proliferative hudsykdommer
TR200400857T4 (tr) Yeni galantamın türevleri ve analogları
EE200000472A (et) Kasvajavastased toimeained
TW200640532A (en) Oral compositions containing biphenol antibacterial compounds
MY143986A (en) Stable aqueous antiplaque oral compositions
MY129176A (en) Tetrahydro gamma-carbolines
IL136911A0 (en) Heterocyclic topoisomerase poisons
NZ334701A (en) Dihydropyrones and use in treating retrovirus infections and diseases
WO2004080408A3 (en) Method of treating cancer with azaspirane compositions
DE60229397D1 (de) Körperpflegezusammensetzungen
MY141869A (en) Mouth rinse compositions
NO20022977L (no) Substituerte homopiperidinylbenzimidazolanaloger som fundiske relaksanter
EP0815111A4 (en) ANALOGS OF N-ACETYLARDEEMIN, METHOD FOR PRODUCING AND USING THESE ANALOGS
PL356141A1 (en) Process for the preparation of pyrazolopyridazine derivatives

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application